Company Quick10K Filing
Cimpress
10-Q 2021-03-31 Filed 2021-04-29
10-Q 2020-12-31 Filed 2021-01-28
10-Q 2020-09-30 Filed 2020-10-29
10-K 2020-06-30 Filed 2020-08-11
10-Q 2020-03-31 Filed 2020-05-06
10-Q 2019-12-31 Filed 2020-01-30
10-Q 2019-09-30 Filed 2019-10-31
10-K 2019-06-30 Filed 2019-08-09
10-Q 2019-03-31 Filed 2019-05-02
10-Q 2018-12-31 Filed 2019-01-31
10-Q 2018-09-30 Filed 2018-11-01
10-K 2018-06-30 Filed 2018-08-10
10-Q 2018-03-31 Filed 2018-05-03
10-Q 2017-12-31 Filed 2018-02-01
10-Q 2017-09-30 Filed 2017-11-03
10-K 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-04-27
10-Q 2016-12-31 Filed 2017-01-30
10-Q 2016-09-30 Filed 2016-10-28
10-K 2016-08-12 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-04-28
10-Q 2015-12-31 Filed 2016-01-29
10-Q 2015-09-30 Filed 2015-10-30
10-K 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-04-30
10-Q 2014-12-31 Filed 2015-01-30
10-Q 2014-09-30 Filed 2014-10-30
10-K 2014-06-30 Filed 2014-08-15
10-Q 2014-03-31 Filed 2014-04-30
10-Q 2013-12-31 Filed 2014-01-31
10-Q 2013-09-30 Filed 2013-10-30
10-K 2013-06-30 Filed 2013-08-15
10-Q 2012-12-31 Filed 2013-02-01
10-Q 2012-09-30 Filed 2012-10-26
10-K 2012-06-30 Filed 2012-08-15
10-Q 2012-03-31 Filed 2012-04-27
10-Q 2011-12-31 Filed 2012-02-01
10-Q 2011-09-30 Filed 2011-10-28
10-K 2011-06-30 Filed 2011-08-17
10-Q 2011-03-31 Filed 2011-04-29
10-Q 2010-12-31 Filed 2011-01-28
10-Q 2010-09-30 Filed 2010-10-29
10-K 2010-06-30 Filed 2010-08-27
10-Q 2010-03-31 Filed 2010-04-30
10-Q 2009-12-31 Filed 2010-01-29
8-K 2021-02-16 Enter Agreement, Exhibits
8-K 2021-01-27 Earnings, Exhibits
8-K 2020-11-25
8-K 2020-10-28
8-K 2020-10-01
8-K 2020-09-28
8-K 2020-07-29
8-K 2020-06-12
8-K 2020-05-05
8-K 2020-05-01
8-K 2020-04-28
8-K 2020-03-31
8-K 2020-02-13
8-K 2020-02-11
8-K 2020-02-10
8-K 2020-02-10
8-K 2020-01-29
8-K 2019-11-22
8-K 2019-11-12
8-K 2019-11-05
8-K 2019-10-30
8-K 2019-10-25
8-K 2019-10-11
8-K 2019-09-17
8-K 2019-08-12
8-K 2019-07-26
8-K 2019-05-01
8-K 2019-02-12
8-K 2019-02-12
8-K 2019-01-29
8-K 2019-01-09
8-K 2019-01-07
8-K 2018-12-20
8-K 2018-11-13
8-K 2018-10-31
8-K 2018-10-01
8-K 2018-09-23
8-K 2018-08-01
8-K 2018-06-26
8-K 2018-06-14
8-K 2018-06-01
8-K 2018-05-29
8-K 2018-05-02
8-K 2018-04-25
8-K 2018-01-31

Cimpress Financials

CMPR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
ENETI INC. (NETI)
024 Pharma (EEIG)
Vivus (VVUS) 41 77% -17.5 -11% 226 289 73 56 -25 -14 243
Clovis Oncology (CLVS) 219 0% -0.0 -56% 717 804 134 0 -400 -394 18
Cementos Pacasmayo Saa (CPAC) 4,145 0% 2,863 1,412 0 0 0 0 4,145
11 Good Energy (ELVN)
Exantas Capital (XAN)
1347 Capital Corp (TFSC)
Bancorp of New Jersey (BKJ) 123 1.0 0% 962 869 0 0 3 15 14
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
30DC (TDCH)
3D Pioneer Systems (DPSM)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-08-122016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash169173208237161675262596551506562476361781341049473777754504326434050444848443531
Accounts Receivable11101213132122202123222225242024263122323936373230525149586766566368706169
Inventory798889878108888712131513182021201820414547575563617875676682
PP&E2612612603792542582594232772932874872953083146133573913927674954914978414955055139235125075019574864954981,026362
Assets5004965295564695905885926206546166026396756729899841,0261,0411,3081,3441,3031,4871,4641,4561,6641,6381,6801,6961,6791,7101,6521,7011,9721,9211,8681,939
Accounts Payable12171716142322262032192323293353587246666674728777116110127121166147152159204168185183
Long-Term Debt01461262292592302382392752082074604333324195006375286776866548308608838016657868398241,0021,0111,0361,165
Liabilities951061041061093233064034214444154124324143947457587597921,0011,1681,0801,2701,2321,2441,5221,5111,5591,5281,4741,5281,4721,5281,7911,7401,6731,950
Stockholders' Equity40538942545036026828218919921020219020726027223221225623524911015815116614799847584119939482128129132-76
Income Statement ($MM)2010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-08-122016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue170234204209212309258250251348288280275371286338334440340380376496437479444577551564567769642631589826662675634
Cost of Revenue6379717578107898988114999996121101134130157126156157198197223214277268279284360319317302411343345326
Gross Profit108155133133134202169162163234189181179250185205204283214224218299239256230300282285283408323315287414319330308
R&D
SG&A7295859198151125120125163136134129155138136143177162153155179169180196207213217205246224217224252209191205
Tax14222351082-11613242357-05920-17135227145145106
Net Income1134231483204-223620411124649-41058-3317-2935-43-352331-2-6-156973420
Cash Flow ($MM)2010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-08-122016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating1974343631811019789837-095351531382362613424641010593316160-3248221710963
Cash Investing-14-9-1-10-12-200-6-15-40-30-14-15-19-32-19-236-46-19-20-131-50-29-160-26-27-227-23-2462-26-22-25-50-32-39-29
Cash Financing-1-6011-9226-20730-53-7-2333-660202-5-99806116-125139-35-71237-19-75-13862-263212-80-33